Shankar Musunuri - 03 Jan 2023 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Chief Executive Officer, Director
Signature
/s/ Shankar Musunuri by Jessica Crespo, his attorney-in-fact
Issuer symbol
OCGN
Transactions as of
03 Jan 2023
Net transactions value
-$122,346
Form type
4
Filing time
17 Feb 2023, 16:11:37 UTC
Previous filing
20 Dec 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Tax liability $47,346 -37,877 -1.7% $1.25 2,190,073 03 Jan 2023 Direct F1
transaction OCGN Common Stock Options Exercise $33,000 +100,000 +4.6% $0.3300 2,290,073 16 Feb 2023 Direct
transaction OCGN Common Stock Sale $108,000 -100,000 -4.4% $1.08 2,190,073 16 Feb 2023 Direct F2, F3
holding OCGN Common Stock 1,145,299 03 Jan 2023 By: KVM Holdings, LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Options Exercise $0 -100,000 -16% $0.000000 529,764 16 Feb 2023 Common Stock 100,000 $0.3300 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed late due to an administrative error.
F2 This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.06 to $1.10. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
F5 The options, initially representing a right to purchase 1,357,145 shares, vest and become exercisable in equal annual installments over three years commencing on May 7, 2021, subject to continued service with the Company on the applicable vesting dates.